Explore

Trendline Trendline
Parabilis Biotech Files for IPO to Fund Cancer Drug Trials

Parabilis Biotech Files for IPO to Fund Cancer Drug Trials

Parabilis Biotech Files for IPO to Fund Cancer Drug Trials
Reuters Reuters
US regulator sues to block Minnesota's first-in-nation ban on prediction markets

US regulator sues to block Minnesota's first-in-nation ban on prediction markets

By Nate Raymond May 19 (Reuters) - The U.S. Commodity Futures Trading Commission on Tuesday filed a lawsuit seeking to block Minnesota from enforcing a newly enacted law that made the state the first nationally to outright ban prediction markets like those run by Kalshi and Polymarket.
Trendline Trendline
Parabilis Medicines Files for IPO to Fund Cancer Drug Trials

Parabilis Medicines Files for IPO to Fund Cancer Drug Trials

Parabilis Medicines Files for IPO to Fund Cancer Drug Trials
Trendline Trendline
Takeda's Layoffs in 2026 Highlight Rising Biopharma Job Cuts

Takeda's Layoffs in 2026 Highlight Rising Biopharma Job Cuts

Takeda's Layoffs in 2026 Highlight Rising Biopharma Job Cuts
Trendline Trendline
Thermo Fisher Scientific Announces Quarterly Dividend to Benefit Shareholders

Thermo Fisher Scientific Announces Quarterly Dividend to Benefit Shareholders

Thermo Fisher Scientific Announces Quarterly Dividend to Benefit Shareholders
Trendline Trendline
BioLineRx to Announce First Quarter 2026 Financial Results with Conference Call

BioLineRx to Announce First Quarter 2026 Financial Results with Conference Call

BioLineRx to Announce First Quarter 2026 Financial Results with Conference Call
Reuters Reuters
Crypto brokerage Blockchain.com confidentially files for IPO

Crypto brokerage Blockchain.com confidentially files for IPO

May 21 (Reuters) - Crypto brokerage Blockchain.com said on Thursday it has confidentially filed for an initial public offering in the United States, as digital assets markets show signs of a rebound after a choppy period.
Trendline Trendline
Discovery Life Sciences Introduces IVDR-Compliant Genomic Panel for EU Oncology Trials

Discovery Life Sciences Introduces IVDR-Compliant Genomic Panel for EU Oncology Trials

Discovery Life Sciences Introduces IVDR-Compliant Genomic Panel for EU Oncology Trials
Trendline Trendline
Hull Street Energy Expands Hydro Portfolio with FirstLight USA Acquisition

Hull Street Energy Expands Hydro Portfolio with FirstLight USA Acquisition

Hull Street Energy Expands Hydro Portfolio with FirstLight USA Acquisition
Trendline Trendline
IGC Pharma Advances Alzheimer's Treatment with CALMA Phase 2 Trial Progress

IGC Pharma Advances Alzheimer's Treatment with CALMA Phase 2 Trial Progress

IGC Pharma Advances Alzheimer's Treatment with CALMA Phase 2 Trial Progress
Trendline Trendline
GenSight Biologics to Discuss Strategic Priorities at General Meeting

GenSight Biologics to Discuss Strategic Priorities at General Meeting

GenSight Biologics to Discuss Strategic Priorities at General Meeting
Trendline Trendline
Oligomerix Completes Phase 1a Study of Alzheimer's Drug OLX-07010, Showing Promise for Future Trials

Oligomerix Completes Phase 1a Study of Alzheimer's Drug OLX-07010, Showing Promise for Future Trials

Oligomerix Completes Phase 1a Study of Alzheimer's Drug OLX-07010, Showing Promise for Future Trials